(1-methyl-1H-pyrazol-4-yl)acetonitrile, 95.0%, 10g

Dibenzoyl-L-tartaric acid, 98.0%, 10kg

N-(2-Hydroxy-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide, 95+%, 100mg

[1-(2-Pyridinyl)propyl]amine, 95.0%, 5g

Ethyl 3,5-dibromo-4-hydroxybenzoate, 95+%, 250g

tert-Butyl 3-nitro-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate, 95.0%, 25g

2-FORMYL-5-(4-CHLOROPHENYL)FURAN, 95.0%, 10g

N1-(2-(4-(2-aminoethyl)piperazin-1-yl)ethyl)ethane-1,2-diamine, 95.0%, 100mg

Ethyl 4-bromopyrazolo[1,5-a]pyridine-2-carboxylate, 95.0%, 1g

Ethyl 4-iodo-1H-pyrrole-2-carboxylate, 95.0%, 250mg

4-(Propan-2-yloxy)benzamide, 95%, 100mg

Copper(II) oxide, min. 97.5%, powder, 250 g, plastic packaging.

3-(Chloromethyl)-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridine, 98%, 1g